Amgen Inc. (AMGN) reported strong Q4 2025 results and provided full-year 2026 guidance that was above Street expectations. The company is managing losses of exclusivity on several large products quite ...

Earnings call Amgen delivered 10% revenue growth in FY2025, with 14 products surpassing $1B in sales and 13 growing double digits. EPS and operating margin expanded, supported by strong contributions ...

Sullivan is professor of health economics and policy and former dean of pharmacy at the University of Washington. Hansen is professor of health economics and policy and chair of the Department of ...

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.6% year on year to $9.87 billion. The company’s full-year revenue guidance of $37.7 billion at ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of $4.76 per share. Earnings were relatively flat year over year as higher ...

The website is targeted at consumers looking to buy drugs without using insurance, meaning that most purchases would not count toward patients' insurance deductibles. US President Donald Trump on ...

Americans will soon be able buy some prescription drugs at discounted cash prices through TrumpRx, a new self-pay website launching Thursday as part of President Donald Trump’s broader push to lower ...

Experts say it’ll help a narrow group of people, citing “no clear advantage for most people” to use the platform The Trump administration announced that its discount drug platform, TrumpRx, will ...

WASHINGTON >> President Donald Trump on Thursday unveiled TrumpRx.gov, a website meant to offer consumers access to discounted prescription medicines and a central pillar of his efforts to lower drug ...

For decades, the United States has led the world in developing groundbreaking medications that allow patients to live longer and healthier lives. Despite these contributions, American families pay ...

The new website promises “low cost prescription drugs,” but will not prescribe or sell drugs directly to the patient Dimitrios Kambouris/Getty The Trump administration has announced that its discount ...

Amgen's Q4 results beat expectations, shares rise modestly MariTide seen as a paradigm-changing weight-loss drug Amgen's 2026 earnings forecast suggests modest upside, says Citi analyst Feb 3 (Reuters ...